Too Many Pancreatic Cancer Patients Not Offered Surgery
FRIDAY, July 28, 2023 -- Surgery is underutilized for the treatment of resectable pancreatic ductal adenocarcinoma (PDAC) in Texas, according to a study recently published in the Journal of Surgical Oncology.
Gilbert Z. Murimwa, M.D., from the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Pancreas | Pancreatic Cancer | Pharmaceuticals | Study